SMTL ID : 6o6f.2 (1 other biounit)

Co-crystal structure of Mcl1 with inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

monomer

Ligands

1 x LOD: (3S)-5'-chloro-5-(cyclobutylmethyl)-2',3',4,5-tetrahydro-2H-spiro[1,5-benzoxazepine-3,1'-indene]-7-carboxylic acid(Non-covalent)

LOD.1: 13 residues within 4Å: Chain A: A.58, F.59, M.62, V.80, M.81, V.84, F.85, R.94, T.97, L.98, F.101, G.102, L.121 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:F.59, A:F.59, A:M.62, A:V.80, A:V.84, A:V.84, A:F.85, A:T.97, A:L.98, A:F.101, A:F.101 Water bridges: A:R.94, A:R.94, A:T.97 Salt bridges: A:R.94 pi-Stacking: A:F.101

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Caenepeel, S. et al., AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies. Cancer Discov (2018)

Release Date

2019-05-15

Peptides

Induced myeloid leukemia cell differentiation protein Mcl-1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Induced myeloid leukemia cell differentiation protein Mcl-1

Related Entries With Identical Sequence